Kernel
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9301 Jordan Ave Ste 102, Chatsworth, Cal...Phone Number
(818) 882-8712Website
www.kernel.comRevenue
$6.9 MillionIndustry
About Kernel
Kernel Org Chart
Is Kernel your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Kernel, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Kernel had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Kernel has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Kernel
Funding: Get notified immidiatlly once Kernel has new funding data
Earning: See what the market has to say on Kernel recently announced quarterly report
Product Launch: Get notified when Kernel launches new products
Check out if Kernel is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Kernel as Masked Content
Find 3 more new buyers
Compare Similar Companies to Kernel
Compare insights from companies similar to Kernel, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kernel is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kernel is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kernel.
Kernel financials insights
Gather financial insights about Kernel, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series C
$53M
Kernel Tech Stack
A closer look at the technologies used by Kernel
Most Recent Scoops
Kernel News & Media
Kernel Launches Cognitive Decline Study Using Flow2 Neuroimaging Technology
LOS ANGELES--(BUSINESS WIRE)--Kernel, a leader in non-invasive neuroimaging technology, is excited to announce the commencement of an observational study focused on characterizing early cognitive decline. The first patients in this study have been measured at the Neurology Center of Southern California (a Profound Research site), one of Kernel’s partners in this study. By leveraging the advanced capabilities of the Flow2 neuroimaging technology, this groundbreaking study aims to detect Mild CogKernel Introduces Flow2: Revolutionary Advanced Neuroimaging Technology Enabling Precision Neuromedicine
LOS ANGELES--(BUSINESS WIRE)--Kernel, a pioneer in neuroimaging technology, is proud to unveil its groundbreaking Flow2 system, a major leap forward in the field of functional neuroimaging. With Flow2, researchers and clinicians now have unprecedented access to robust, fMRI-like functional neuroimaging in a quick and user-friendly headset, making precision neuromedicine more accessible than ever before. Flow2 incorporates state-of-the-art time-domain functional near-infrared spectroscopy (TD-fNCybin Announces Publication of Sponsored Feasibility Study Validating Kernel’s Flow1 Neuroimaging Technology Measuring Psychedelic Effects on the Brain
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, commends Kernel, a leader in non-invasive neuroimaging, on their publication titled "Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS" in the journal Scientific Reports from the NatureKernel's Revolutionary Neuroimaging Technology, Flow1, Validated in Published Feasibility Study on Measuring Psychedelic Effects
LOS ANGELES--(BUSINESS WIRE)--Kernel, a leader in non-invasive neuroimaging, announces the publication of their study "Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS," in the journal Scientific Reports from the Nature Portfolio of Journals. The study, sponsored by Cybin Inc. (NEO:CYBN) (NYSE American:CYBN), underscores the ability of Kernel’s Flow1 system to capture and analyze brain changes resulting from the administration of a psych
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kernel
Kernel For Clinics is a pioneering company focused on advancing brain health through accessible and evidence-based measurements. Their technology combines non-invasive brain measurements with advanced algorithms to provide detailed insights into brain function, enabling users to track cognitive health over time. Targeting both wellness and medical... Read More